[DOI] [PubMed] [Google Scholar] 119.Vidal-Rohr M, Craig JP, Davies LN, Wolffsohn JS
In SURMOUNT-1, 72 weeks of tirzepatide induced mean WL of 1622.5% in people without diabetes compared to 2.4% with placebo, with no sign of the weight plateauing, suggesting that there may be further WL with long-term use [46]
Differences Across Age Groups and Markets The research also revealed differences across demographics and geographies
But, he said, These findings provide some reassurance regarding risks of adverse pregnancy outcomes following unintentional GLP-1 exposure in early pregnancy. He added, however, that the study doesnt shed light on the safety of GLP-1 use past the first trimester
B.HartmannB.ThulesenJ.HansenB
Muscle matters, and if youre cutting weight, we want to make sure youre not cutting what counts